Canada Life
DNA icon

Canada Life’s Ginkgo Bioworks DNA Stock Holding History

Canada Life’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,739
Closed -$194K – 2075
2024
Q2 		$194K Buy
14,739
+3,454
+31% +$103K ﹤0.01% 1815
2024
Q1 		$525K Buy
11,285
+8,152
+260% +$422K ﹤0.01% 1675
2023
Q4 		$210K Buy
3,133
+240
+8% +$14.7K ﹤0.01% 1838
2023
Q3 		$209K Buy
2,893
+1,067
+58% +$85.3K ﹤0.01% 1848
2023
Q2 		$136K Buy
1,826
+282
+18% +$16.7K ﹤0.01% 1881
2023
Q1 		$82K Buy
1,544
+192
+14% +$12.2K ﹤0.01% 2002
2022
Q4 		$92K Buy
1,352
+587
+77% +$54K ﹤0.01% 2002
2022
Q3 		$96K Buy
765
+7
+0.9% +$834 ﹤0.01% 1993
2022
Q2 		$72K Buy
+758
New +$92.5K ﹤0.01% 1972

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return